Skip to content
Catalyst

methylphenidatePapers

Papers about methylphenidate

papers
1,014
42 years, by papers

Newest first

601 to 650 of 1,014

Every paper here, unless its row says otherwiseIndexed under methylphenidate in PubMed's chemical list; returned by a PubMed search for methylphenidate

  • Modulation of social influence by methylphenidate.

    Neuropsychopharmacology2012PMID 22318197

  • Methylphenidate and risk of serious cardiovascular events in adults.

    The American journal of psychiatry2012PMID 22318795

  • Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate.

    Journal of developmental and behavioral pediatrics2012PMID 22343483

  • Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day.

    Journal of child and adolescent psychopharmacology2012PMID 22364402

  • Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.

    Journal of clinical psychopharmacology2012PMID 22367664

  • Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.

    Journal of child neurology2012PMID 22447850

  • Methylphenidate (MPH) promotes visual cortical activation in healthy adults in a cued visuomotor task.

    Journal of neural transmission (Vienna, Austria2012PMID 22460297

  • Differences in the in vitro and in vivo pharmacokinetic profiles of once-daily modified-release methylphenidate formulations in Canada: examination of current bioequivalence criteria.

    Clinical therapeutics2012PMID 22512898

  • Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate.

    European archives of psychiatry and clinical neuroscience2012PMID 22526730

  • Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.

    Journal of child and adolescent psychopharmacology2012PMID 22537358

  • Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.

    Clinical therapeutics2012PMID 22578232

  • Effects of methylphenidate on basic and higher-order oculomotor functions.

    Journal of psychopharmacology (Oxford, England)2012PMID 22588495

  • Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study.

    Journal of child neurology2012PMID 22596014

  • Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial.

    Attention deficit and hyperactivity disorders2012PMID 22622628

  • Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

    The Lancet. Neurology2012PMID 22658702

  • Adderall abuse on college campuses: a comprehensive literature review.

    Journal of evidence-based social work2012PMID 22694135

  • Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate.

    The Journal of clinical psychiatry2012PMID 22780962

  • Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.

    Human psychopharmacology2012PMID 22806822Indexed under methylphenidate in PubMed's chemical list

  • The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate.

    Journal of the neurological sciences2012PMID 22824349

  • In for a penny, in for a pound: methylphenidate reduces the inhibitory effect of high stakes on persistent risky choice.

    The Journal of neuroscience2012PMID 22993421

  • Methylphenidate-mediated reduction in prefrontal hemodynamic responses to working memory task: a functional near-infrared spectroscopy study.

    Human psychopharmacology2012PMID 23011591

  • Methylphenidate as a treatment for stuttering: a case report.

    European review for medical and pharmacological sciences2012PMID 23090813

  • The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.

    Postgraduate medicine2012PMID 23095424

  • Comparison of prescription drug costs in the United States and the United Kingdom, part 3: methylphenidate.

    Pharmacotherapy2012PMID 23108719

  • Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.

    Acta medica Iranica2012PMID 23292622

  • Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine.

    Journal of child and adolescent psychopharmacology2012PMID 23362511

  • Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients.

    BMJ supportive & palliative care2012PMID 24654216

  • A one year trial of methylphenidate in the treatment of ADHD.

    Journal of attention disorders2011PMID 20071637

  • Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.

    Journal of attention disorders2011PMID 20410322

  • A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate.

    Journal of attention disorders2011PMID 20495161

  • Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke--a randomized, double-blind, placebo-controlled trial.

    Acta neurologica Scandinavica2011PMID 20569228

  • Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis.

    Journal of attention disorders2011PMID 20837981

  • Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.

    Psychiatry research2011PMID 20863575

  • Methylphenidate increases choice of cigarettes over money.

    Nicotine & tobacco research2011PMID 21059817

  • Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate.

    Journal of child psychology and psychiatry, and allied disciplines2011PMID 21073458

  • Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions.

    Child psychiatry and human development2011PMID 21165694

  • Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate.

    Progress in neuro-psychopharmacology & biological psychiatry2011PMID 21185347

  • Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study.

    Journal of clinical psychopharmacology2011PMID 21192153

  • Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.

    Biological psychiatry2011PMID 21193172

  • Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis.

    Journal of pain and symptom management2011PMID 21251796

  • Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis.

    CNS drugs2011PMID 21254791

  • Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial.

    Journal of negative results in biomedicine2011PMID 21276244

  • Factors associated with response to methylphenidate in advanced cancer patients.

    The oncologist2011PMID 21282671

  • Reward processing in male adults with childhood ADHD--a comparison between drug-naïve and methylphenidate-treated subjects.

    Psychopharmacology2011PMID 21298512

  • Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD.

    European neuropsychopharmacology2011PMID 21303732

  • Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment.

    The American journal of psychiatry2011PMID 21406463

  • Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder.

    Clinical pediatrics2011PMID 21436147

  • Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder.

    Neuropsychopharmacology2011PMID 21451498

  • Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.

    Neurology2011PMID 21464430

  • Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.

    Expert review of neurotherapeutics2011PMID 21469923

The next 50 papers

← Previous 50